AXGN
HOLD / NEUTRALMeanRevComposite
46.10
Technical
58.50
Fundamental
42.00
Rank
—
Price
49.25
Hurst
0.10
As of
Oct 29, 2026
Daily
Axogen, Inc.
HealthcareMedical DevicesAxogen develops and sells medical products for treating peripheral nerve injuries worldwide. Its product portfolio includes nerve grafts made from donated human tissue, surgical connectors and protective wraps for nerve repair, and soft tissue matrices derived from animal and human sources. The company supplies these devices to hospitals and surgical centers through distributors, primarily serving plastic surgeons, orthopedic specialists, and hand surgeons.
Market cap
$2.9B
P/E (trailing)
—
P/E (forward)
69.98
PEG ratio
99.04
Dividend yield
0.00%
Beta
1.17
52w range
21.93 – 52.91
Return on equity
-10.35%
Profit margin
-11.96%
Revenue growth
+26.20%
Earnings growth
+300.00%
Price history
1Y: 49.37 (+122.2%) · range 22.22–51.73
Cycle position
62/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 28 · NOT READY · exit proximity 50
Conviction
40/ 100 · maturity 29%
VScore.1613
Buildup.2870
EMA entry setup.3528
Fundamentals.2142
Volume profile
POC
44.45
Price vs POC
+11.1%
Overhead supply
7%
Runway
open sky
Value area 37.87–46.89 · 7% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.933 | Oct 30, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +25.10% | +25.10% | mature |
| 40d | +4.93% | +25.10% | mature |